Neurogene Inc.

NASDAQ: NGNE · Real-Time Price · USD
22.96
1.29 (5.95%)
At close: Jun 05, 2025, 3:59 PM
5.95%
Bid 21.13
Market Cap 327.46M
Revenue (ttm) 925K
Net Income (ttm) -80.87M
EPS (ttm) -4.36
PE Ratio (ttm) -5.27
Forward PE -4.31
Analyst Buy
Ask 23.2
Volume 265,642
Avg. Volume (20D) 278,495
Open 17.82
Previous Close 21.67
Day's Range 17.82 - 23.17
52-Week Range 6.88 - 74.49
Beta 1.58

About NGNE

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NGNE
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for NGNE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
3 weeks ago
-7.12%
Neurogene shares are trading lower after Baird dow... Unlock content with Pro Subscription
6 months ago
-42.58%
Neurgogene shares are trading lower after the company announced it brought its high-dose gene therapy trial to a halt after a serious adverse event in a Rett syndrome patient.